Bio Protocol vs USDC — how do they compare? Bio Protocol trades at Rp438.81 (market cap Rp995,47M, Rp176,04M 24h volume), while USDC trades at Rp17,874 (market cap Rp1.286,9T, Rp125,07T 24h volume). The key difference: USDC is far larger — about 1292756.2× Bio Protocol's market cap, and Bio Protocol's supply is capped (2,3B / 3,3B BIO (69%)) while USDC's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and USDC for 63 Days on average.
| BIO | USDC | |
|---|---|---|
Market Cap | Rp995,47M | Rp1.286,9T |
Volume (24h) | Rp176,04M | Rp125,07T |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 72,1B USDC |
Typical Hold Time | 18 Days | 63 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp424.33 with a market cap of Rp965.85M, showing neutral technical signals amid bearish moving averages. The token's circulating supply of 2.3M out of 3.3M max indicates 69% circulation with an average hold time of 17 days. Recent technical indicators show mixed signals with RSI in neutral territory while ADX suggests some buying momentum. Support and resistance levels are well-defined between Rp398 and Rp500.
Overall outlook remains neutral with key opportunities in protocol adoption growth, though risks include limited liquidity and typical crypto volatility. Investors should monitor network activity closely as the token operates in a competitive blockchain ecosystem without major recent protocol updates.
USDC is currently trading at Rp17,878 with a market cap of Rp1.286 trillion, showing bearish technical signals with moving averages indicating selling pressure while oscillators remain neutral. The token faces key support at Rp17,658 and resistance at Rp17,876, with RSI levels suggesting potential oversold conditions. As a stablecoin pegged to the US dollar, USDC maintains its primary utility for crypto trading pairs and DeFi applications.
Overall outlook remains stable-focused with limited price movement expected given its peg mechanism. Key opportunities include continued DeFi integration and cross-chain expansion, while major risks involve regulatory scrutiny of stablecoins and potential de-pegging events during market stress. Investors should monitor on-chain liquidity and reserve attestations for stability assurance.
What Pluang investors did over the last 30 days
Latest headlines on both assets
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →USD Coin is a stablecoin that is pegged to the U.S. dollar on a 1:1 basis. The stablecoin was originally launched on a limited basis in September 2018. Put simply, USD Coin’s mantra is 'digital money for the digital age'— and the stablecoin is designed for a world where cashless transactions are becoming more common. USD Coin has aimed to stand head and shoulders over competitors in several ways. One of them concerns transparency and assurance that users will be able to withdraw 1 USDC and receive $1 in return without any issues.
Read more on USDC →